Search
for
Sort by
Research 30 of 431
- Novel cosmeceuticals from plants—An industry guided review
- Nanotechnology in Cosmetics: An Overview
- Androgen Receptor Blockade Induces the Phagocytosis of MRSA and Pseudomonas aeruginosa by Monocyte-Derived Macrophages In Vitro
- Treatment of invasive aspergillosis with itraconazole
- Subject Index
- Mapping penetration of cosmetic compounds into hair fibers using time‐of‐flight secondary ion mass spectrometry (TOF‐SIMS)
- Lupus erythematosus: systemic and cutaneous manifestations
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- ADVANCES IN PSORIASIS THERAPY
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Cytostatics and immunosuppressive drugs
- Management of Dermatologic Toxicities
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- TONGUE, RED
- Granulocyte Colony-Stimulating Factor Treatment of Cyclic Neutropenia With Recurrent Oral Aphthae
- Resolution of Waldenström's macroglubulinemia related isolated neutropenia by immunochemotherapy
- A 30-Year-Old Man with Recurrent Scaling and Itching of the Scalp
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
- Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Albendazole treatment of echinococcosis in humans: Effects on microsomal metabolism and drug tolerance
- Mitoxantrone
- Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Principles of chemotherapy
- Presumptive Albendazole Toxicosis in 12 Alpacas